Physician profile
Mark S Choh
NPI 1023283611
$3,535.32
in general payments reported to CMS, 2019-2025
30 companies · $88.43 in 2025
The $88.43 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $174 · 2021: $956 · 2022: $399 · 2023: $470 · 2024: $854 · 2025: $88.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,383 · Consulting Fee: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,382.81 |
| Consulting Fee | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $656.64 | 2021-2025 | Maxtack, Eea, Ligasure |
| Novo Nordisk INC | $451.71 | 2019-2025 | Wegovy |
| Aimmune Therapeutics, INC. | $369.57 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $336.73 | 2020-2024 | Gattex, Eohilia |
| Covidien LP | $305.77 | 2019-2020 | |
| Ethicon US, LLC | $200.74 | 2019-2023 | Echelon Flex |
| W. L. Gore & Associates, INC. | $185.42 | 2020-2024 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Smith+Nephew, INC. | $156.57 | 2019-2022 | |
| Intuitive Surgical, INC. | $152.82 | 2019-2023 | Da Vinci Surgical System |
| Davol INC. | $113.14 | 2019-2021 | |
| Centinel Spine, LLC | $104.17 | 2023 | Prodisc L |
| Shire North American Group INC | $55.88 | 2019 | |
| Coopersurgical, INC. | $49.84 | 2021 | |
| Teleflex LLC | $48.49 | 2024 | Titan Sgs |
| Boston Scientific Corporation | $39.71 | 2024 | Spyglass Discover |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $32.63 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Hologic Sales and Service, LLC | $31.34 | 2022 | |
| Integra Lifesciences Corporation | $29.44 | 2021 | |
| Osiris Therapeutics INC. | $23.67 | 2019 | |
| Sirius Medical Systems | $23.07 | 2024 | Pintuition |
| Tei Biosciences INC | $22.03 | 2019 | |
| Endo Pharmaceuticals INC. | $20.33 | 2020 | |
| Lilly USA, LLC | $18.15 | 2024 | Zepbound, Jardiance |
| Baxter Healthcare | $17.81 | 2022 | |
| Conmed Corporation | $16.44 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.39 | 2024 | Exparel |
| Acera Surgical, INC. | $14.76 | 2019 | |
| Becton, Dickinson and Company | $14.22 | 2019 | |
| Echosens North America, INC. | $13.93 | 2023 | Fibroscan |
| Braintree Laboratories, INC. | $13.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Choh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.